LEVORPHANOL TARTRATE (Roxane Laboratories, Inc)


Welcome to the PulseAid listing for the LEVORPHANOL TARTRATE drug offered from Roxane Laboratories, Inc. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Roxane Laboratories, Inc
NON-PROPRIETARY NAME: LEVORPHANOL TARTRATE
SUBSTANCE NAME: LEVORPHANOL TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2000-03-31
END MARKETING DATE: 2017-12-16


LEVORPHANOL TARTRATE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLEVORPHANOL TARTRATE from Roxane Laboratories, Inc
LABELER NAME: Roxane Laboratories, Inc
DEA SCHEDULE: CII
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2000-03-31
END MARKETING DATE: 2017-12-16
PRODUCT ID: 0054-0438_15628d27-e0fd-40dd-bbfa-54a5490c924f
PRODUCT NDC: 0054-0438
APPLICATION NUMBER: ANDA074278

Other LEVORPHANOL TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Roxane Laboratories, IncLEVORPHANOL TARTRATE
Sentynl Therapeutics, Inc.Levorphanol Tartrate